BAY 73-4506 is an orally bioavailable multikinase inhibitor targeting both the tumor and its vasculature. BAY 73-4506 binds to and inhibits VEGFR-2 and -3, and tumor cell signaling kinases (RET, KIT, PDGFR, and Raf), which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. This drug shows potent, oral activity in a wide variety of preclinical xenograft models.
To inquire quotation or to ask questions, please send email to sales@chemrenpharm.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.
¡¡
¡¡
M.Wt: 482.82
Formula: C21H15ClF4N4O3
Solubility: DMSO
Purity: >99%
Storage: at -20¡æ2years
BAY 73-4506 is an orally bioavailable multikinase inhibitor targeting both the tumor and its vasculature. BAY 73-4506 binds to and inhibits VEGFR-2 and -3, and tumor cell signaling kinases (RET, KIT, PDGFR, and Raf), which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. This drug shows potent, oral activity in a wide variety of preclinical xenograft models.
To inquire quotation or to ask questions, please send email to sales@chemrenpharm.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.
